<DOC>
	<DOCNO>NCT02423226</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy CT guide 125I seed implant plus systemic chemotherapy locally recurrent rectum cancer .</brief_summary>
	<brief_title>Computed Tomography-guided Brachytherapy Plus Chemotherapy Locally Recurrent Rectum Cancer</brief_title>
	<detailed_description>The primary aim study determine safety efficacy CT guide 125I seed implant plus systemic chemotherapy locally recurrent rectum cancer.The patient recurrence pelvic pelvic wall rectal resection treat 125I seed implant plus chemotherapy chemotherapy alone . The side-effect , tumor response survival data record .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>Limited locoregional recurrence include solitary recurrence primary tumor bed , solitary intraabdominal peritoneal recurrence , single regional lymph node recurrence ( 3 lymph node ) base diagnosis CT , confirm percutaneous puncture biopsy Secondline treatment advance colorectal cancer , irinotecan previously use . Age range 1870 year old ECOG performance status 01 Life expectancy 3 month Adequate organ function Previous serious cardiac disease History malignancies except cure basal cell carcinoma skin carcinoma insitu uterine cervix Pregnant lactate woman Chronic inflammatory bowel disease intestinal obstruction Serious uncontrolled disease intercurrent infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>